Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.0K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corneal Allograft for Near Vision Improvement in Emmetropic Presbyopia: 4-Year Safety and Efficacy Results From a Prospective European Multicenter Clinical Trial.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

Impact of Donor Lenticule Depth on the Outcome of Allogeneic Corneal Inlay Treatment for Presbyopia.

Cornea·2026
Same author

[Sugammadex for anaphylaxis due to rocuronium].

Die Anaesthesiologie·2025
Same author

Fit-for-Future: Lessons Learned from the COVID-19 Pandemic in Primary Extracorporeal Membrane Oxygenation (ECMO) Transports of Acute Respiratory Distress Syndrome (ARDS) Patients.

Journal of clinical medicine·2024
Same author

Evaluation of the Use of Intraoperative OCT in Routine Surgery: A Two-year Comparison.

Klinische Monatsblatter fur Augenheilkunde·2023
Same author

Lenticule Extraction.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2022

Related Experiment Video

Updated: Dec 16, 2025

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.1K

Optimization model for UV-riboflavin corneal cross-linking.

Silvia Schumacher1, Michael Mrochen, Jeremy Wernli

  • 1IROC AG, Zurich, Switzerland.

Investigative Ophthalmology & Visual Science
|January 7, 2012
PubMed
Summary
This summary is machine-generated.

A new theoretical model predicts corneal stiffness increases from riboflavin ultraviolet-A cross-linking. This model correlates absorbed radiant exposure with stiffness, enabling customized treatments based on patient corneal thickness.

More Related Videos

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.2K
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K

Related Experiment Videos

Last Updated: Dec 16, 2025

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
12:25

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

8.1K
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
05:56

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

9.2K
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K

Area of Science:

  • Ophthalmology
  • Biomedical Engineering
  • Materials Science

Background:

  • Corneal cross-linking (CXL) enhances corneal stiffness.
  • Riboflavin and ultraviolet-A (UVA) light are used in CXL.
  • Predicting CXL treatment outcomes requires understanding its biophysical mechanisms.

Purpose of the Study:

  • Develop a theoretical model for riboflavin UVA-CXL.
  • Predict corneal stiffness increase based on UVA intensity, riboflavin concentration, and treatment time.
  • Correlate theoretical predictions with experimental data.

Main Methods:

  • Derived a theoretical model using Fick's second law, Lambert-Beer's law, and photopolymerization kinetics.
  • Performed stress-strain experiments on porcine corneal strips to measure Young's modulus.
  • Correlated experimental stiffness increase with simulated polymerization increase.

Main Results:

  • The model calculates spatial and temporal intensity and concentration distributions.
  • Absorbed radiant exposure linearly correlates with measured stiffness increase (threshold 1.7 J/cm²).
  • Relative stiffness increase linearly correlates with theoretical polymer increase per tissue depth.

Conclusions:

  • The theoretical model accurately predicts the spatial distribution of stiffness increase post-CXL.
  • This model can personalize CXL treatments based on individual corneal characteristics.
  • Enables customized CXL protocols for various ocular conditions.